A. Avlami

609 total citations
23 papers, 444 citations indexed

About

A. Avlami is a scholar working on Infectious Diseases, Clinical Biochemistry and Epidemiology. According to data from OpenAlex, A. Avlami has authored 23 papers receiving a total of 444 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 9 papers in Clinical Biochemistry and 8 papers in Epidemiology. Recurrent topics in A. Avlami's work include Bacterial Identification and Susceptibility Testing (9 papers), Antibiotic Resistance in Bacteria (8 papers) and Antimicrobial Resistance in Staphylococcus (5 papers). A. Avlami is often cited by papers focused on Bacterial Identification and Susceptibility Testing (9 papers), Antibiotic Resistance in Bacteria (8 papers) and Antimicrobial Resistance in Staphylococcus (5 papers). A. Avlami collaborates with scholars based in Greece, United States and Russia. A. Avlami's co-authors include Ioanna Stefanou, N.J. Legakis, T. Kordossis, Nikolaos V. Sipsas, G. Petrikkos, Alexandra Vasilakopoulou, Aristea Velegraki, Panayotis T. Tassios, Alkiviadis Vatopoulos and Chris Kosmidis and has published in prestigious journals such as Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

A. Avlami

23 papers receiving 419 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Avlami Greece 11 162 135 133 77 71 23 444
J Barnishan United States 11 114 0.7× 143 1.1× 112 0.8× 65 0.8× 80 1.1× 13 421
H. Darbas France 13 151 0.9× 83 0.6× 126 0.9× 62 0.8× 115 1.6× 34 480
M. Łuczak Poland 15 226 1.4× 219 1.6× 153 1.2× 62 0.8× 105 1.5× 58 629
Ping-Cherng Chiang Taiwan 13 133 0.8× 146 1.1× 164 1.2× 58 0.8× 47 0.7× 22 460
T. Schülin Netherlands 14 304 1.9× 249 1.8× 131 1.0× 106 1.4× 112 1.6× 18 575
Ron Bosboom Netherlands 13 230 1.4× 150 1.1× 74 0.6× 129 1.7× 81 1.1× 17 465
Sydney M. Bell Australia 13 84 0.5× 83 0.6× 79 0.6× 64 0.8× 72 1.0× 24 488
David V. Alcid United States 10 108 0.7× 130 1.0× 70 0.5× 98 1.3× 45 0.6× 17 377
Jan Weile Germany 13 141 0.9× 84 0.6× 179 1.3× 99 1.3× 140 2.0× 18 495
A. Sawicka–Grzelak Poland 13 229 1.4× 92 0.7× 142 1.1× 117 1.5× 96 1.4× 70 555

Countries citing papers authored by A. Avlami

Since Specialization
Citations

This map shows the geographic impact of A. Avlami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Avlami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Avlami more than expected).

Fields of papers citing papers by A. Avlami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Avlami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Avlami. The network helps show where A. Avlami may publish in the future.

Co-authorship network of co-authors of A. Avlami

This figure shows the co-authorship network connecting the top 25 collaborators of A. Avlami. A scholar is included among the top collaborators of A. Avlami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Avlami. A. Avlami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vallianou, Natalia G., et al.. (2014). Prevalence of macrolide, lincosamide, and streptogramin resistance among staphylococci in a tertiary care hospital in Athens, Greece. Journal of Chemotherapy. 27(6). 319–323. 10 indexed citations
2.
Avlami, A., E. Malamou-Lada, O. Paniara, et al.. (2010). Detection of metallo-β-lactamase genes in clinical specimens by a commercial multiplex PCR system. Journal of Microbiological Methods. 83(2). 185–187. 33 indexed citations
3.
Vasilakopoulou, Alexandra, Mina Psichοgiou, L. S. Tzouvelekis, et al.. (2009). Prevalence and Characterization of Class 1 Integrons in Escherichia coli of Poultry and Human Origin. Foodborne Pathogens and Disease. 6(10). 1211–1218. 21 indexed citations
4.
Giakkoupi, Panagiota, S. Vourli, Christos Hadjichristodoulou, et al.. (2008). Epidemiology of Metalloenzyme-ProducingPseudomonas aeruginosain a Tertiary Hospital in Greece. Journal of Chemotherapy. 20(3). 307–311. 3 indexed citations
5.
Avlami, A., et al.. (2004). Blood culture results during the period 1995-2002 in a Greek tertiary care hospital. Clinical Microbiology and Infection. 10(7). 667–670. 7 indexed citations
6.
Tzouvelekis, L. S., et al.. (2004). Quinolone resistance among Escherichia coli strains from community-acquired urinary tract infections in Greece. Clinical Microbiology and Infection. 10(1). 75–78. 31 indexed citations
7.
Vasilakopoulou, Alexandra, et al.. (2003). Balantidium coli Pneumonia in an Immunocompromised Patient. Scandinavian Journal of Infectious Diseases. 35(2). 144–146. 26 indexed citations
8.
Papaparaskevas, Joseph, Panayotis T. Tassios, V. Kalapothaki, et al.. (2002). Epidemiology of multiresistant Enterococcus avium isolates in a Greek tertiary care hospital. International Journal of Antimicrobial Agents. 20(6). 432–437. 4 indexed citations
9.
Avlami, A., et al.. (2001). Lactobacillus Rhamnosus Endocarditis Complicating Colonoscopy. Journal of Infection. 42(4). 283–285. 51 indexed citations
10.
Papaparaskevas, Joseph, Alkiviadis Vatopoulos, Panayotis T. Tassios, et al.. (2000). Diversity among high-level aminoglycoside-resistant enterococci. Journal of Antimicrobial Chemotherapy. 45(3). 277–283. 21 indexed citations
11.
Archimandritis, Athanasios J., et al.. (2000). Rapid urease test is less sensitive than histology in diagnosing Helicobacter pylori infection in patients with non‐variceal upper gastrointestinal bleeding. Journal of Gastroenterology and Hepatology. 15(4). 369–373. 44 indexed citations
12.
Papaparaskevas, Joseph, et al.. (1999). The first clinical isolate of Enterococcus faecium with the VanB phenotype in a teaching hospital in Greece. Clinical Microbiology and Infection. 5(12). 763–765. 4 indexed citations
13.
Avlami, A., et al.. (1998). First report ofCryptococcus laurentiimeningitis and a fatal case ofCryptococcus albiduscryptococcaemia in AIDS patients. Medical Mycology. 36(5). 335–339. 79 indexed citations
14.
Avlami, A., et al.. (1997). Bone marrow infection caused by Actinobacillus ureae in a rheumatoid arthritis patient. Journal of Infection. 35(3). 298–299. 7 indexed citations
15.
Konstantopoulos, Kostas, et al.. (1994). Bacteroides fragilis Arthritis in a Sickle Cell-Thalassaemia Patient. Scandinavian Journal of Infectious Diseases. 26(4). 495–497. 7 indexed citations
16.
Yataganas, Xenophon, Yannis Rombos, G. Vayopoulos, John Meletis, & A. Avlami. (1991). Randomized Clinical Trial Comparing Ceftriaxone/Amikacin versus Ceftazidime/Amikacin as Initial Therapy of Febrile Episodes in Neutropenic Patients. Chemotherapy. 37(5). 376–381. 5 indexed citations
17.
Giamarellou, Helen, et al.. (1986). Efficacy of Sulbactam plus Ampicillin in Gynecologic Infections. Clinical Infectious Diseases. 8(Supplement_5). S579–S582. 13 indexed citations
18.
Giamarellou, Helen, et al.. (1982). Ornidazole versus Clindamycin: Comparative Evaluation in the Treatment of 140 Serious Anaerobic Infections. Chemotherapy. 28(6). 502–511. 5 indexed citations
19.
Giamarellou, Helen, et al.. (1981). In-vitro studies with ceftazidime. Journal of Antimicrobial Chemotherapy. 8(suppl B). 73–77. 9 indexed citations
20.
Giamarellou, Helen, et al.. (1981). Ornidazole as a single drug in the treatment of mixed aerobic-anaerobic infections. Journal of Antimicrobial Chemotherapy. 7(5). 569–574. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026